Strides Arcolab gets USFDA approval for Methoxsalen Softgel Capsules

To be manufactured at Bangalore facility

Strides Arcolab announced that it has received approval from the United State Food & Drug Administration (USFDA) for Methoxsalen Capsules USP, 10mg (Softgel Capsules).

The product will be manufactured at the Company's USFDA approved Oral dosage facility at Bangalore and marketed directly by Strides in the US market.

Powered by Capital Market - Live News